Renal response to converting enzyme blockade.

Area of Science:

• Nephrology
• Pharmacology
• Cardiovascular Research

Background:

• Hypertension management often involves targeting the renin-angiotensin-aldosterone system.
• Converting enzyme inhibitors (CEIs) play a crucial role in this system.
• Understanding the specific renal effects of CEIs like enalaprilic acid is important for optimizing treatment.

Purpose of the Study:

• To investigate the direct renal hemodynamic and biochemical effects of enalaprilic acid.
• To determine the dose-response relationship of enalaprilic acid on renal blood flow and converting enzyme activity.
• To elucidate the relationship between converting enzyme inhibition and renal vasodilation.

Main Methods:

• Incremental doses of enalaprilic acid were infused into the renal artery of hypertensive patients.
• Renal blood flow was measured using xenon-washout technique.
• Converting enzyme activity, angiotensin II levels, and renin secretion were assessed via renal artery and vein blood sampling.

Main Results:

• Enalaprilic acid demonstrated a dose-related suppression of converting enzyme activity, peaking at 1 microgram/kg per min.
• Angiotensin II levels decreased in parallel with converting enzyme suppression.
• Renal blood flow increased significantly at a dose of 3 micrograms/kg per min, suggesting a threshold for vasodilation.

Conclusions:

• Systemic suppression of converting enzyme activity is a prerequisite for achieving renal vasodilation.
• The renal vascular response to enalaprilic acid occurs independently of systemic blood pressure reduction.
• These findings highlight the complex interplay between CEI dosage, enzyme inhibition, and renal hemodynamics.